AbbVie Announces U.S. FDA Approval of VENCLEXTA® (venetoclax tablets) in Combination with Rituximab as a Fixed Duration Treatment for Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Patients Who Have Received One Prior Therapy

You can not survive tomorrow if you don’t have partnerships – Visioning the future

During Skåne Innovation Week, we gathered some sharp minds to envision the future with us. Together with Andreas Bergh, Lund University, Olof Dellien, Arm, Martin Gren, Axis Communications, P-A Hedin, Sigma Connectivity, Jeanna Kimbré and Johan Svenér, Sony and Henrik Wiberg, Volvo Car Sverige we talked about future trends, challenges and opportunities. We were guided through the day by the amazing Trine Grönlund.

AI Speeds Up Pharmaceutical Testing

Oslo Cancer Cluster member Immunitrack has landed investments worth millions. The money will be used to develop a computer program that can predict how the immune system will react to different substances.

AbbVie Teams Up with Hidradenitis Suppurativa Patients Around the World to Raise Awareness About the Disease

Hidradenitis suppurativa (HS) is a painful, debilitating, chronic inflammatory skin disease estimated to affect 1 - 4 percent of the world's population(1),(2). Voices of HS Unite encourages people affected by HS to share their stories online, to raise awareness, reduce stigma and to have a conversation with their dermatologist

Meet our Mentors – Staffan Gestrelius, co-founder of Qliktech

Ideon Science Park has been mentioned as one out of 13 brain belts where the smartest people in the world live and work. Let´s make even more use of that! With the Ideon Mentorship Program we want to connect the experienced leaders in the park with entrepreneurs who want to learn how to grow their business. The mentors, the experienced leaders, have serious scale-up skills to teach and important connections to offer to the right mentee. By helping each other they can both grow and who knows – it could be the start of something fantastic! Here is your chance to get to know one of our amazing mentors – Staffan Gestrelius – a bit better.

AbbVie Announces Final Results of Tender Offer

AbbVie today announced the final results of its modified Dutch auction tender offer, which expired at 12:00 midnight, New York City time, at the end of May 29, 2018.